Adams Street Partners

Adams Street Partners is a global private market investment management firm based in Chicago, Illinois, specializing in private equity and venture capital investments. Established in 1972, the firm has developed a strong reputation for performance and a disciplined investment approach, focusing primarily on growth-stage companies through buyouts while also engaging in seed, early, and later-stage investments. With a diverse investment portfolio that includes business products, consumer services, healthcare, information technology, and various technology sectors, Adams Street Partners serves institutional investors by leveraging its extensive knowledge and experience gained over more than four decades. As an independent, employee-owned firm, it is committed to delivering exceptional client service and maintaining investor confidence through a deep understanding of the global private marketplace.

Jeffrey Akers

Partner and Head of Secondary Investments

Matthew Auran

Vice President, Primary Investments and Member of Diversity, Equity and Inclusion Committee

Matthew Autrey

Partner, Primary Investments and Member of Diversity, Equity and Inclusion Committee

Troy Barnett

Partner, Secondary Investments

Mattias de Beau

Partner, Primary Investments and Member of the Environmental, Social and Governance (ESG) Committees

Philipp Bohren

Partner and Head, Information Technology

David Brett

Partner and Head of Co-Investments

Paul Burgess

Vice President, Information Technology

Gail Carey

Principal

James Charalambides

Partner, Head of European Private Credit and Member of the Private Credit Investment Committee

Weihan Chong

Associate

Frederick Chung

Partner, Head of Credit Underwriting, Private Credit and Member of the Private Credit Investment Committee

Ali Cliff

Principal, Growth Equity and Member of the Environmental, Social and Governance (ESG) Committee

Jeffrey Diehl

Managing Partner and Head of Investments

Brian Dudley

Partner, Growth Equity, Member of Growth Equity Investment and Portfolio Construction Committees and Editorial Board Member

T. Bondurant French

Chairman

Jonathan Goh

Principal, Primary Investments

Joseph Goldrick

Partner, Secondary Investments

Miguel Gonzalo

Partner and Head of Investment Strategy and Risk Management

Terry Gould

Senior Partner, Growth Equity and Member of the Growth Equity Investment Committee

Doris Guo

Partner, Primary Investments

Yohan Hill

Principal, Director of ESG and Responsible Investing, Investment Strategy and Risk Management and Chairperson of Environmental, Social, and Governance Committee

Gregory Holden

Partner, Secondary Investments

Morgan Holzaepfel

Partner, Primary Investments and Member of the Diversity, Equity and Inclusion Committee

Brijesh Jeevarathnam

Partner, Global Head of Fund Investments, Chairperson of the Investment Committee and Member of the Executive Committee

Dennis Kan

Vice President, Private Credit

Alex Kessel

Partner, Co-Investments and Member of the Co-Investment, Impact Investment and Diversity, Equity and Inclusion Committees

Steve Landau

Partner, Head of Product Strategy, Chair of the New Product Committee and Member of the Diversity, Equity and Inclusion and Investment Pricing Committees

Ali Lauer

Investor

Justin Lawrence

Partner, Private Credit and Member of the Private Credit Investment, Portfolio Construction and Environmental, Social and Governance (ESG) Committees

Alejandra Lesch

Partner, Investment Strategy and Risk Management

Marcus Lindroos

Principal, Primary Investments and Member of the Diversity, Equity and Inclusion Committee

Terrie Liu

Principal, Wealth Management and Member of the Diversity, Equity and Inclusion Committee

Michael Lucarelli

Partner, Wealth Management

Mark Lutostanski

Principal, Private Equity Middle Office, Client Operations

Michael Lynn

General Partner Partner

Mhahesh Madhavan

Partner, Information Technology

Saguna Malhotra

Partner, Head of Global Buyout Fund Investments and Member of the Primary Investment and Diversity, Equity and Inclusion Committee

Megan McKillen

Vice President, Finance

Cesar Mendoza

Associate

Clinton Miller

Principal, Secondary Investments and Member of the Strategic Digital Initiatives and Diversity, Equity and Inclusion Committee

Steven Montag

Principal, Corporate Controller, Finance and Member of the Diversity, Equity and Inclusion Committee

Rachel Moore

Senior Associate, Investment Strategy and Risk Management

Ross Morrison

Partner, Primary Investments and Member of the Charitable Giving Committee

Robin Murray

Partner and Head of Growth Equity Investments

Pinal Nicum

Partner, Secondary Investments and Member of the Secondary Investment Committee

Alicia Pando

Partner, CTO and Member of the Executive and Operating Committee

Nolan Pauker

Principal, Private Credit

Gabrielle Penn

Principal

Benjamin Peters

Principal, Information Technology

Derek Piunti

Principal, Information Technology

Jamie Raibley

Principal, Treasury Operations, Client Operations

Leland Richards

Partner, Private Credit

William Sacher

Partner, Head of Private Credit, Chairman of the Private Credit Investment Committee and Member of the Executive Committee

Mustafa Salih

Principal, Co-Investments

Kushal Shah

Vice President, Secondary Investments

Emily Shiau

Principal, Private Credit and Member of the Diversity, Equity and Inclusion Committee

Alexander Silver

Principal, Secondary Investments and Member of the Environmental, Social and Governance (ESG) Committee

Yar-Ping Soo

Partner, Primary Investments and Member of the Primary Investment Committee

Mark Terwilliger

Associate

Tobias True

Partner, Investment Strategy and Risk Management, Member of the Portfolio Construction Committee and Chairman of the Charitable Giving Committee

Ervis Vukaj

Vice President, Private Credit and Member of the Diversity, Equity and Inclusion Committee

Eduardo Vázquez

Principal, Head of IT Infrastructure, CISO and Member of the Diversity, Equity and Inclusion Committee

James B. Walker

Partner, Global Head of Wealth and Member of the Executive, New Product and Environmental, Social and Governance (ESG) Committees

Jim Walker

Partner and COO

Benjamin Wallwork

Partner, Co-Investments and Member of the Co-Investment, Portfolio Construction and Environmental, Social and Governance (ESG) Committees

Andy Wang

Partner, Primary Investments

Craig Waslin

Partner, Co-Investments

Steven Wilde

Partner

Ling Jen Wu

Principal, Primary Investments

Jian Zhang

Partner, Investment Strategy and Risk Management

Yu Zhang

Principal

233 past transactions

Cyberhaven

Series D in 2025
Cyberhaven, Inc., established in 2014 and headquartered in Boston, Massachusetts, specializes in enterprise cybersecurity. The company's core offering is a Data Detection and Response platform designed to safeguard intellectual property from theft and insider threats. This platform assesses internal actions across an organization, identifying risky behaviors before they result in a breach. It provides full-context data tracing to minimize false positives and negatives, and accelerates incident response investigations, enabling clients to protect their data efficiently. Cyberhaven's technology covers the protection of sensitive documents across various platforms, including Office 365, on-premise SharePoint, and Google Apps. The company operates globally with additional offices in Palo Alto, California; Lausanne, Switzerland; and Kiev, Ukraine.

Highnote

Series B in 2025
Highnote is an embedded finance company that specializes in developing a unified virtual payment platform designed to manage complex payment processing workflows. The platform is built to be developer-friendly, allowing product and engineering teams across various digital enterprises to seamlessly integrate virtual and physical payment card capabilities, including commercial and consumer prepaid, debit, credit, and charge cards. Highnote's architecture features open APIs and a fully integrated issuer processor, providing merchants and businesses with the control, flexibility, and speed needed to enhance their offerings. By facilitating the embedding of advanced payment solutions into existing products, Highnote helps businesses create significant value for their users while driving growth and establishing a distinctive brand presence.

Solera Health

Series E in 2025
Solera Health, Inc. is a preventive care benefits manager based in Phoenix, Arizona, that operates a technology platform designed to connect payers, doctors, patients, and non-clinical healthcare providers. Founded in 2015, Solera's platform serves as a single marketplace for health plans and medical providers, facilitating access to community organizations and digital therapeutics that address a variety of health concerns, including obesity, hypertension, diabetes prevention, mental health, and tobacco cessation. By matching members with tailored health programs, Solera emphasizes value-based health solutions that ensure timely access to appropriate health technologies and promote improved health outcomes.

Zip

Series D in 2024
Zip is a developer of an intelligent purchase request platform that simplifies the process for employees to initiate purchase or vendor requests. The platform streamlines approvals by automatically routing requests to the appropriate stakeholders across various departments, including procurement, finance, IT, data security, and legal. By integrating with major ERP and P2P solutions, Zip assists users in creating purchase requests and draft purchase orders efficiently. The system recommends preferred vendors, checks pricing against benchmarks, and ensures compliance, ultimately reducing the time spent on coordinating approvals and cutting costs for organizations.

Level AI

Series C in 2024
Level AI is a company based in Mountain View, California, that specializes in redefining customer contact center operations through the use of conversational intelligence. Its artificial intelligence platform is designed to automate tedious workflows and enhance the overall customer experience. By providing real-time insights, Level AI empowers agents to efficiently address customer needs at critical moments. The platform equips front-line workers with advanced tools that combine the speed of a supercomputer with a natural, human-like interaction style, enabling organizations to effectively manage customer interactions across various marketing channels.

BillionToOne

Series D in 2024
BillionToOne Inc. is a precision diagnostics company focused on developing advanced genetic testing platforms that detect and quantify diseases at the molecular level. Established in 2016 and headquartered in Menlo Park, California, the company offers a noninvasive prenatal screening solution called UNITY, which analyzes fetal cell-free DNA from a single blood sample provided by the mother. This test can identify single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and thalassemia, thereby providing a safer alternative to invasive procedures like amniocentesis. Beyond prenatal diagnostics, BillionToOne is also developing oncology assays that enable the detection of actionable mutations and monitor tumor burden through blood samples, allowing for more precise therapy selection and monitoring. The company's innovative technologies aim to make genetic testing both accurate and accessible, ensuring that a broader spectrum of patients can benefit from advanced medical diagnostics.

Nomad Health

Series E in 2024
Nomad Health, Inc. is an online marketplace that connects clinicians with freelance and permanent clinical job opportunities in the United States. Founded in 2015 and based in New York, the company provides a platform where doctors and nurses can search for employment based on various criteria such as location, pay rate, and medical specialty. Nomad Health aims to streamline the healthcare staffing process by replacing traditional methods with a modern, efficient technology platform. The service not only simplifies job searches but also manages digital resumes and credentials, facilitating communication between clinicians and healthcare facilities. This innovative approach addresses the complexities of healthcare staffing, enhancing the experience for both job seekers and providers.

Cyberhaven

Series C in 2024
Cyberhaven, Inc., established in 2014 and headquartered in Boston, Massachusetts, specializes in enterprise cybersecurity. The company's core offering is a Data Detection and Response platform designed to safeguard intellectual property from theft and insider threats. This platform assesses internal actions across an organization, identifying risky behaviors before they result in a breach. It provides full-context data tracing to minimize false positives and negatives, and accelerates incident response investigations, enabling clients to protect their data efficiently. Cyberhaven's technology covers the protection of sensitive documents across various platforms, including Office 365, on-premise SharePoint, and Google Apps. The company operates globally with additional offices in Palo Alto, California; Lausanne, Switzerland; and Kiev, Ukraine.

Altruist

Series E in 2024
Altruist is a company focused on enhancing the accessibility and affordability of independent financial advice. It offers a digital investment platform that streamlines operations for financial advisors, automating research and helping identify client needs. By improving efficiency, Altruist empowers advisors to reduce their fees, allowing clients to pay less while increasing their financial confidence. The company supports thousands of financial professionals, ultimately benefiting tens of millions of individuals seeking a better experience with their finances.

Turquoise Health

Series B in 2024
Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, Turquoise Health has developed a platform that enables users to browse and compare prices for elective services offered by hospitals. The platform facilitates price comparisons between various insurance services and allows individuals to search by procedure and provider. This innovative marketplace connects patients, providers, and payers, empowering individuals to save money on elective treatments while helping healthcare organizations attract both cash-paying and insured patients.

Cato Networks

Venture Round in 2023
Cato Networks Ltd. is a provider of a cloud-based network Security-as-a-Service platform designed to enhance enterprise connectivity and security. Founded in 2015 and headquartered in Tel Aviv, Israel, with additional offices in locations including San Jose, California, and London, the company offers an integrated solution that combines software-defined wide area networking (SD-WAN) with advanced security features. This platform enables organizations to securely connect all their locations, users, and data while optimizing application access and performance. Cato Networks helps businesses reduce costs associated with traditional MPLS connections, improves overall performance for global locations and cloud applications, and simplifies network management through its cloud-native service. Its offerings include WAN optimization, firewall protection, secure web gateway, and secure remote access, making it suitable for distributed, mobile, and cloud-enabled enterprises.

Aircall

Series D in 2023
Aircall, established in 2014 and headquartered in Paris, France, specializes in cloud-based call center software for startups and small to medium-sized businesses. Its core product, Aircall, is a Software as a Service (SaaS) application that enables companies to set up and manage phone support online. Aircall's voice platform integrates with popular productivity and helpdesk tools, making it easy for businesses to manage and monitor customer support and sales engagement in real-time.

BillionToOne

Series C in 2022
BillionToOne Inc. is a precision diagnostics company focused on developing advanced genetic testing platforms that detect and quantify diseases at the molecular level. Established in 2016 and headquartered in Menlo Park, California, the company offers a noninvasive prenatal screening solution called UNITY, which analyzes fetal cell-free DNA from a single blood sample provided by the mother. This test can identify single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and thalassemia, thereby providing a safer alternative to invasive procedures like amniocentesis. Beyond prenatal diagnostics, BillionToOne is also developing oncology assays that enable the detection of actionable mutations and monitor tumor burden through blood samples, allowing for more precise therapy selection and monitoring. The company's innovative technologies aim to make genetic testing both accurate and accessible, ensuring that a broader spectrum of patients can benefit from advanced medical diagnostics.

DispatchHealth

Venture Round in 2022
DispatchHealth Management, LLC is a provider of on-demand mobile and virtual healthcare services, founded in 2013 and headquartered in Denver, Colorado. The company offers a wide range of services, including evaluation and treatment for acute injuries and illnesses, laceration repair, splinting of injured extremities, and management of conditions like nosebleeds and catheter placements. It also facilitates medication administration, laboratory testing, outpatient imaging arrangements, and coordination with primary care physicians and home health agencies. By delivering care directly to patients in their homes or workplaces, DispatchHealth aims to enhance the capabilities of existing care teams while providing high-quality, cost-effective healthcare solutions.

US Med-Equip

Debt Financing in 2022
US Med-Equip, Inc. is a Houston-based company that specializes in the rental, sale, maintenance, and management of movable medical equipment for hospitals across the United States. Founded in 1995, the company offers a wide range of equipment, including anesthesia machines, beds, defibrillators, EKG machines, and respiratory devices, as well as furnishings like bassinets and recliners. US Med-Equip is recognized for its commitment to customer service, providing 24/7 support and personalized attention. The company is ISO 9001:2015 certified and employs advanced technology for equipment tracking and management, including an online platform called mySMARTS Portal and the STAR Trax Asset Management solution. In addition to rental and sales, US Med-Equip offers services such as biomedical repair, equipment buyouts, and preventative maintenance alerts, ensuring that healthcare providers can effectively manage their medical equipment and enhance patient care.

ClassDojo

Series D in 2022
ClassDojo, Inc. is an online school communication platform founded in 2011 and based in San Francisco, California. The platform connects teachers, students, and families, fostering close-knit communities that enhance the educational experience. It allows educators to share classroom activities, including photos and videos, and facilitates communication through features like Class Story and private messaging with parents. ClassDojo aims to engage students and their families by providing a space where learning can be shared and celebrated, ultimately enriching the educational environment and promoting collaboration both in and out of the classroom. The company, previously known as Class Twist, Inc., rebranded to ClassDojo, Inc. in December 2017.

Nomad Health

Venture Round in 2022
Nomad Health, Inc. is an online marketplace that connects clinicians with freelance and permanent clinical job opportunities in the United States. Founded in 2015 and based in New York, the company provides a platform where doctors and nurses can search for employment based on various criteria such as location, pay rate, and medical specialty. Nomad Health aims to streamline the healthcare staffing process by replacing traditional methods with a modern, efficient technology platform. The service not only simplifies job searches but also manages digital resumes and credentials, facilitating communication between clinicians and healthcare facilities. This innovative approach addresses the complexities of healthcare staffing, enhancing the experience for both job seekers and providers.

FalconX

Series D in 2022
FalconX, Ltd. is a cryptocurrency brokerage and digital asset trading platform founded in 2018 and based in San Mateo, California. The company specializes in blockchain technology and fintech, offering clients access to cryptocurrency markets for trading, credit, and clearing. FalconX utilizes data science and machine learning to ensure reliable execution of mid-to-large size trades, smart routing prices across multiple liquidity sources. This approach helps eliminate slippage and hidden fees, making it an attractive option for hedge funds, proprietary trading firms, and other institutional clients seeking efficient and cost-effective trading solutions.

Reify Health

Series D in 2022
Reify Health, Inc. is a Baltimore-based company that specializes in cloud-based software aimed at enhancing the development of new therapies within the life sciences sector. Founded in 2010, Reify Health provides solutions designed to streamline clinical research processes, particularly in the area of patient enrollment for clinical trials. Its flagship product, StudyTeam, allows research sponsors, contract research organizations, and clinical sites to achieve faster and more predictable enrollment outcomes. By automating and simplifying the enrollment process, Reify Health's software enables teams to concentrate on essential tasks that drive research success, thereby improving overall productivity and optimizing study budgets.

Remote

Series C in 2022
Remote is a global HR solutions provider that facilitates international hiring and payroll management for distributed teams. They offer a platform designed to help companies recruit top talent worldwide, ensuring compliance with local laws while streamlining project allocation and payments. This enables businesses to expand their workforce globally, enhancing productivity and employment opportunities.

BillionToOne

Series C in 2022
BillionToOne Inc. is a precision diagnostics company focused on developing advanced genetic testing platforms that detect and quantify diseases at the molecular level. Established in 2016 and headquartered in Menlo Park, California, the company offers a noninvasive prenatal screening solution called UNITY, which analyzes fetal cell-free DNA from a single blood sample provided by the mother. This test can identify single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and thalassemia, thereby providing a safer alternative to invasive procedures like amniocentesis. Beyond prenatal diagnostics, BillionToOne is also developing oncology assays that enable the detection of actionable mutations and monitor tumor burden through blood samples, allowing for more precise therapy selection and monitoring. The company's innovative technologies aim to make genetic testing both accurate and accessible, ensuring that a broader spectrum of patients can benefit from advanced medical diagnostics.

Dremio

Series E in 2022
Dremio Corporation, founded in 2015 and based in Santa Clara, California, specializes in data lake technology that enhances data management and analytics. Its flagship product, Dremio, is a data lake engine that accelerates analytical processing and enables self-service capabilities for users, including data engineers, analysts, and data scientists. By providing a structured query language query engine, Dremio eliminates the need for traditional data movement into proprietary data warehouses, thereby streamlining data access and analysis. The platform supports various analytical tools and is designed to improve productivity and efficiency, allowing organizations to derive greater value from their data without the complexities of creating additional data structures or extracts.

Nomad Health

Series D in 2021
Nomad Health, Inc. is an online marketplace that connects clinicians with freelance and permanent clinical job opportunities in the United States. Founded in 2015 and based in New York, the company provides a platform where doctors and nurses can search for employment based on various criteria such as location, pay rate, and medical specialty. Nomad Health aims to streamline the healthcare staffing process by replacing traditional methods with a modern, efficient technology platform. The service not only simplifies job searches but also manages digital resumes and credentials, facilitating communication between clinicians and healthcare facilities. This innovative approach addresses the complexities of healthcare staffing, enhancing the experience for both job seekers and providers.

Reify Health

Series C in 2021
Reify Health, Inc. is a Baltimore-based company that specializes in cloud-based software aimed at enhancing the development of new therapies within the life sciences sector. Founded in 2010, Reify Health provides solutions designed to streamline clinical research processes, particularly in the area of patient enrollment for clinical trials. Its flagship product, StudyTeam, allows research sponsors, contract research organizations, and clinical sites to achieve faster and more predictable enrollment outcomes. By automating and simplifying the enrollment process, Reify Health's software enables teams to concentrate on essential tasks that drive research success, thereby improving overall productivity and optimizing study budgets.

Visier

Series E in 2021
Visier, Inc. is a developer of a cloud-based workforce intelligence platform that provides organizations with comprehensive analytics and solutions for managing their workforce. Founded in 2010 and headquartered in Vancouver, Canada, with an additional office in San Jose, California, Visier's offerings enable human resources professionals to efficiently recruit, retain, and develop talent while providing insights into workforce dynamics. The platform, known as Visier People, includes pre-built analytics that address a wide range of HR and business questions, facilitating strategic decision-making. It caters to various industries, including healthcare, financial services, technology, energy, manufacturing, and retail. Visier's subscription model ensures ongoing support and continuous delivery of new business value, enhancing the overall effectiveness of workforce planning and people analytics for its clients.

Aircall

Series D in 2021
Aircall, established in 2014 and headquartered in Paris, France, specializes in cloud-based call center software for startups and small to medium-sized businesses. Its core product, Aircall, is a Software as a Service (SaaS) application that enables companies to set up and manage phone support online. Aircall's voice platform integrates with popular productivity and helpdesk tools, making it easy for businesses to manage and monitor customer support and sales engagement in real-time.

Iterable

Series E in 2021
Iterable, Inc. is a consumer growth marketing and user engagement platform based in San Francisco, California, founded in 2013. It caters primarily to mid-market and enterprise B2C companies across various sectors, including e-commerce, media, financial services, and political campaigns. The platform enables marketers to engage users through multiple channels such as email, mobile, social media, and the web, providing features like real-time segmentation, automation, customization, and A/B testing. Additionally, Iterable's solutions support engineers in triggering campaigns, exporting metrics, and managing workflows. By harnessing artificial intelligence and behavior-driven data, Iterable helps organizations create individualized communications that enhance customer interactions and drive growth throughout the customer lifecycle.

Homeward

Series B in 2021
Homeward, Inc. is a company that operates a platform designed to streamline the home buying and selling process. By allowing buyers to secure credit for an all-cash offer on a new home before selling their existing property, Homeward facilitates a smoother transition for its clients. The company offers a service known as The Homeward Way, which assists users in finding homes and making competitive cash offers. Additionally, Homeward provides rental solutions for new homes during the period when customers are selling their current residences. Founded in 2018 and headquartered in Austin, Texas, Homeward is expanding its services in states such as Texas, Georgia, and Colorado, with plans to grow its reach nationwide. By partnering with real estate agents, the company aims to help clients navigate the complexities of the housing market, offering accurate home valuations and modern mortgage solutions to enhance the buying and selling experience.

Actium Health

Series B in 2021
Actium Health is a developer of a healthcare customer relationship management platform that focuses on enhancing patient engagement within healthcare systems. The company utilizes health-system data intelligence, machine learning, and predictive analytics to analyze clinical and payer data. By offering AI-driven recommendations tailored to individual patient needs, Actium empowers healthcare providers to transform into member-focused enterprises. This approach enables organizations to effectively manage patients at elevated risk, promoting growth in service lines and fostering enhanced retention, loyalty, and lifetime value. Through its highly personalized activation tools, Actium Health unlocks untapped value in the healthcare sector.

ThreatQuotient

Debt Financing in 2021
ThreatQuotient, Inc. is a company that specializes in developing a threat intelligence platform designed to help organizations manage and respond to cyber threats effectively. Founded in 2013 and headquartered in Reston, Virginia, with additional operations in Germany and Australia, ThreatQuotient offers a platform that integrates and correlates various external intelligence sources with internal security processes and analytics. This platform provides contextual and operationalized intelligence, enabling organizations to streamline their security operations by focusing on prioritized threats. Its features include Indicator Nurturing, which tailors indicators of compromise to specific infrastructures, and the automation of processes to enhance investigation efficiencies and collaboration among security teams. By integrating with existing technologies, ThreatQuotient’s solutions support multiple use cases such as incident response, threat hunting, and vulnerability management. The company has been recognized for its product excellence and leadership in the cybersecurity industry, receiving several awards for its contributions to enhancing security operations.

ThreatQuotient

Venture Round in 2021
ThreatQuotient, Inc. is a company that specializes in developing a threat intelligence platform designed to help organizations manage and respond to cyber threats effectively. Founded in 2013 and headquartered in Reston, Virginia, with additional operations in Germany and Australia, ThreatQuotient offers a platform that integrates and correlates various external intelligence sources with internal security processes and analytics. This platform provides contextual and operationalized intelligence, enabling organizations to streamline their security operations by focusing on prioritized threats. Its features include Indicator Nurturing, which tailors indicators of compromise to specific infrastructures, and the automation of processes to enhance investigation efficiencies and collaboration among security teams. By integrating with existing technologies, ThreatQuotient’s solutions support multiple use cases such as incident response, threat hunting, and vulnerability management. The company has been recognized for its product excellence and leadership in the cybersecurity industry, receiving several awards for its contributions to enhancing security operations.

Mineralys Therapeutics

Series A in 2021
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for hypertension. The company is advancing its lead product candidate, MLS-101, a highly selective and potent aldosterone synthase inhibitor licensed from Mitsubishi Tanabe Pharma Corporation. Mineralys aims to provide a targeted treatment for patients with uncontrolled hypertension, particularly those who do not achieve adequate blood pressure control despite using multiple antihypertensive medications. By addressing the underlying factors associated with elevated aldosterone levels, Mineralys seeks to improve treatment outcomes for individuals suffering from this condition.

Advise Insurance

Series A in 2021
Advise Insurance is a Medicare concierge agency dedicated to serving seniors by assisting them in comparing and selecting health insurance options that best suit their needs. The company operates a platform that simplifies the Medicare process, fostering strong connections between elderly clients and their healthcare providers. Advise Insurance partners with medical professionals to conduct seminars on Medicare, offering transparent reviews of various plans. This approach ensures that seniors receive proper guidance in navigating their healthcare choices. Additionally, Advise Health Holdings manages Bloom Insurance, a value-based Medicare enrollment platform that employs licensed agents across the contiguous United States, further enhancing its commitment to supporting healthy senior living through comprehensive insurance solutions.

Redox

Series D in 2021
Redox, Inc. is a healthtech startup incubator based in Madison, Wisconsin, founded in February 2014. The company specializes in developing a comprehensive integration platform that facilitates the secure and efficient exchange of healthcare data among delivery organizations and technology vendors. By standardizing data and maintaining seamless integrations, Redox aims to eliminate technical barriers in healthcare systems, enabling vendors and providers to focus on improving patient experiences. The firm is particularly focused on early-stage investments in healthcare information technology, including lab information systems and FDA-approved medical devices, striving to make healthcare data more useful and accessible.

PerimeterX

Series D in 2021
PerimeterX, Inc. is a cybersecurity company that specializes in developing solutions to prevent automated attacks and malicious web behavior. Founded in 2014 and headquartered in San Mateo, California, with additional locations in London, Miami, and a subsidiary in Tel Aviv, the company offers a suite of products aimed at protecting web infrastructure. Its flagship solutions, known as PerimeterX Bot Defender, provide real-time defenses against various types of bot attacks, including those targeting websites, mobile applications, and APIs. By leveraging behavioral analytics and advanced threat detection techniques, PerimeterX helps organizations in sectors such as e-commerce, travel, and media safeguard their digital assets from account abuse, web scraping, and marketing fraud. The company's innovative approach has garnered recognition, including being listed among the top cybersecurity startups and promising artificial intelligence firms.

Freeman Spogli

Debt Financing in 2020
Freeman Spogli Management Co., L.P., established in 1983, is a private equity firm headquartered in Los Angeles, California, with an additional office in New York. The company specializes in acquiring middle-market companies, providing growth capital, and facilitating leveraged recapitalizations, management buyouts, and corporate carve-outs. Freeman Spogli primarily invests in the consumer sector, focusing on retail, restaurants, direct marketing, e-commerce, consumer products, and retail services, as well as the distribution sector, with an emphasis on wholesale and business-to-business distribution. The firm typically invests between $25 million and $150 million in equity, targeting companies with enterprise values between $100 million and $700 million and EBITDA between $10 million and $50 million. Freeman Spogli seeks board seats in its portfolio companies and may also participate in add-on acquisition opportunities.

Robinhood

Series F in 2020
Robinhood Financial LLC is an online brokerage firm that provides commission-free trading services to self-directed investors through its mobile application and website. Established in 2012 and headquartered in Menlo Park, California, the company, previously known as Chronos Financial, LLC, rebranded in 2013. As a subsidiary of Robinhood Markets, Inc., Robinhood offers a comprehensive platform for trading stocks, options, exchange-traded funds (ETFs), and cryptocurrencies. The firm aims to democratize access to financial markets, allowing users to trade and manage their investments easily. Its innovative platform includes features such as fractional shares, recurring investments, and IPO access. Robinhood generates revenue primarily by routing user orders to market makers, facilitating transactions across various asset classes.

Palvella Therapeutics

Series C in 2020
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Wayne, Pennsylvania, established in 2015. The company specializes in developing and commercializing targeted therapies for serious and rare genetic skin diseases, focusing on addressing the root causes of these conditions. Its lead product candidate, QTORIN, is an anhydrous gel formulated to ensure drug stability at room temperature while enabling effective distribution into skin layers where various dermatologic pathologies occur. Palvella Therapeutics is committed to serving patient populations that have been overlooked, with an initial emphasis on conditions such as microcystic lymphatic malformations and cutaneous venous malformations, leveraging its patented QTORIN platform to advance its therapeutic pipeline.

Aircall

Series C in 2020
Aircall, established in 2014 and headquartered in Paris, France, specializes in cloud-based call center software for startups and small to medium-sized businesses. Its core product, Aircall, is a Software as a Service (SaaS) application that enables companies to set up and manage phone support online. Aircall's voice platform integrates with popular productivity and helpdesk tools, making it easy for businesses to manage and monitor customer support and sales engagement in real-time.

Couchbase

Series G in 2020
Couchbase, Inc. is a provider of NoSQL database solutions designed for enterprise web and mobile applications. The company's flagship product, Couchbase Server, is an open-source, document-oriented database optimized for high-performance, interactive applications. Couchbase also offers a comprehensive platform that includes Couchbase Lite, a lightweight embedded database for mobile devices, and Couchbase Sync Gateway, which facilitates data synchronization between devices and the cloud. Additionally, Couchbase provides a fully-managed Database-as-a-Service (DBaaS) known as Couchbase Cloud, tailored for multi-cloud environments, as well as a Kubernetes Operator for cloud-native database management. The company's solutions are utilized across various industries, including social networking, e-commerce, gaming, and media. Headquartered in Santa Clara, California, Couchbase also has a presence in Manchester, United Kingdom. The company, originally founded as Membase, Inc. in 2008, rebranded as Couchbase, Inc. in 2011.

Homeward

Venture Round in 2020
Homeward, Inc. is a company that operates a platform designed to streamline the home buying and selling process. By allowing buyers to secure credit for an all-cash offer on a new home before selling their existing property, Homeward facilitates a smoother transition for its clients. The company offers a service known as The Homeward Way, which assists users in finding homes and making competitive cash offers. Additionally, Homeward provides rental solutions for new homes during the period when customers are selling their current residences. Founded in 2018 and headquartered in Austin, Texas, Homeward is expanding its services in states such as Texas, Georgia, and Colorado, with plans to grow its reach nationwide. By partnering with real estate agents, the company aims to help clients navigate the complexities of the housing market, offering accurate home valuations and modern mortgage solutions to enhance the buying and selling experience.

Epirium Bio

Series A in 2019
Epirium Bio, Inc. is a biopharmaceutical company based in San Diego, California, focused on developing therapeutics for cardiovascular diseases, metabolic syndrome, and disorders characterized by mitochondrial dysfunction. Founded in 2008, the company leverages unique insights into mitochondrial biology and tissue regeneration to create a small molecule platform aimed at improving muscle strength and facilitating tissue regeneration. Epirium Bio's innovative approach addresses significant clinical needs in treating neuromuscular, neurodegenerative, and mitochondrial disorders, enabling healthcare providers to better support patients suffering from conditions such as muscular dystrophy.

Punchh

Series C in 2019
Punchh Inc. is a company that specializes in developing mobile solutions aimed at enhancing customer loyalty and engagement for the restaurant industry. Founded in 2010 and headquartered in San Mateo, California, Punchh provides a comprehensive platform that includes features such as loyalty programs, referral systems, online ordering, and gift card functionalities. By utilizing artificial intelligence and machine learning, the platform enables businesses to create personalized experiences that foster customer retention and increase lifetime value. Additionally, Punchh's technology integrates seamlessly with existing point-of-sale systems and various third-party applications, facilitating a unified approach to customer engagement across multiple channels. With a presence in global markets, Punchh serves nearly 200 enterprise brands, helping them strengthen customer relationships and drive revenue growth.

Icosavax

Series A in 2019
Icosavax, Inc. is a biotechnology company based in Seattle, Washington, founded in 2017. The company specializes in developing vaccines utilizing its proprietary virus-like particle (VLP) platform technology. This innovative approach allows for the multivalent, particle-based display of complex viral antigens, which is aimed at generating broad and durable immune responses. Icosavax focuses primarily on life-threatening respiratory diseases, with its lead vaccine candidate, IVX-121, targeting respiratory syncytial virus (RSV) in older adults. The company's pipeline also includes candidates for human metapneumovirus (hMPV) and SARS-CoV-2, reflecting its commitment to advancing vaccine solutions for infectious diseases.

PerimeterX

Series C in 2019
PerimeterX, Inc. is a cybersecurity company that specializes in developing solutions to prevent automated attacks and malicious web behavior. Founded in 2014 and headquartered in San Mateo, California, with additional locations in London, Miami, and a subsidiary in Tel Aviv, the company offers a suite of products aimed at protecting web infrastructure. Its flagship solutions, known as PerimeterX Bot Defender, provide real-time defenses against various types of bot attacks, including those targeting websites, mobile applications, and APIs. By leveraging behavioral analytics and advanced threat detection techniques, PerimeterX helps organizations in sectors such as e-commerce, travel, and media safeguard their digital assets from account abuse, web scraping, and marketing fraud. The company's innovative approach has garnered recognition, including being listed among the top cybersecurity startups and promising artificial intelligence firms.

VillageMD

Series B in 2019
VillageMD is a healthcare management services company focused on supporting primary care physicians. Founded in 2013 and headquartered in Chicago, Illinois, the company provides a comprehensive platform that includes tools, technology, operations, and staffing support. It collaborates with physician groups, independent practice associations, and health systems to enhance quality of care, improve patient experiences, and reduce costs. VillageMD's services encompass management, clinical innovation, analytics, and value-based contract negotiation, enabling healthcare providers to achieve better clinical outcomes across various populations. The company operates in multiple markets, including Chicago, Georgia, Houston, Indianapolis, Kentucky, Michigan, New Hampshire, and Austin.

MyHealthTeam

Series B in 2019
MyHealthTeams, Inc., established in 2011 and headquartered in San Francisco, develops and operates online social networking platforms for individuals living with or caring for those with chronic health conditions. The company's platforms, including MyAutismTeam, MyBCTeam, and others, connect users with similar conditions, enabling them to share experiences, seek advice, and access medically-approved content. MyHealthTeams also conducts research to inform clinical trial design and offers patient education programs.

TurnKey Vacation Rentals

Series E in 2019
TurnKey Vacation Rentals is a full-service property management company specializing in luxury and premium vacation rental homes in sought-after U.S. travel destinations. The company is recognized for delivering a consistent and high-quality guest experience akin to that of a fine hotel, while simultaneously enhancing the management and marketing efforts for vacation rental homeowners. TurnKey utilizes proprietary smart home technology, including digital smart locks and noise decibel monitors, to streamline operations and improve guest satisfaction. By integrating local teams with advanced technology, TurnKey aims to provide exceptional experiences for both guests and homeowners, ensuring every stay meets high standards of quality and service.

Actium Health

Series A in 2019
Actium Health is a developer of a healthcare customer relationship management platform that focuses on enhancing patient engagement within healthcare systems. The company utilizes health-system data intelligence, machine learning, and predictive analytics to analyze clinical and payer data. By offering AI-driven recommendations tailored to individual patient needs, Actium empowers healthcare providers to transform into member-focused enterprises. This approach enables organizations to effectively manage patients at elevated risk, promoting growth in service lines and fostering enhanced retention, loyalty, and lifetime value. Through its highly personalized activation tools, Actium Health unlocks untapped value in the healthcare sector.

Solera Health

Series C in 2019
Solera Health, Inc. is a preventive care benefits manager based in Phoenix, Arizona, that operates a technology platform designed to connect payers, doctors, patients, and non-clinical healthcare providers. Founded in 2015, Solera's platform serves as a single marketplace for health plans and medical providers, facilitating access to community organizations and digital therapeutics that address a variety of health concerns, including obesity, hypertension, diabetes prevention, mental health, and tobacco cessation. By matching members with tailored health programs, Solera emphasizes value-based health solutions that ensure timely access to appropriate health technologies and promote improved health outcomes.

GoCardless

Series E in 2019
GoCardless Limited, established in 2011 and headquartered in London, specializes in online payment processing services for businesses. It facilitates bank-to-bank transfers through web-based gateways and APIs, enabling merchants to collect one-off and recurring payments. The company's key products include GoCardless for simple online payments, GoCardless Pro for building recurring payment ecosystems, and Success+ for predicting and managing payment failures. GoCardless offers international payment collection, with connections to over 2,300 banks across Europe, and securely provides bank account data to enhance products and manage risk. With strategic alliances like Zuora, Inc., GoCardless serves over 75,000 businesses worldwide, operating from offices in London, Paris, Munich, Melbourne, and New York.

PerimeterX

Series C in 2019
PerimeterX, Inc. is a cybersecurity company that specializes in developing solutions to prevent automated attacks and malicious web behavior. Founded in 2014 and headquartered in San Mateo, California, with additional locations in London, Miami, and a subsidiary in Tel Aviv, the company offers a suite of products aimed at protecting web infrastructure. Its flagship solutions, known as PerimeterX Bot Defender, provide real-time defenses against various types of bot attacks, including those targeting websites, mobile applications, and APIs. By leveraging behavioral analytics and advanced threat detection techniques, PerimeterX helps organizations in sectors such as e-commerce, travel, and media safeguard their digital assets from account abuse, web scraping, and marketing fraud. The company's innovative approach has garnered recognition, including being listed among the top cybersecurity startups and promising artificial intelligence firms.

Inspira Financial

Private Equity Round in 2019
Inspira Financial is a provider of technology-enabled solutions focused on health, wealth, retirement, and benefits, aimed at simplifying the financial journey for individuals and institutions. The company serves over 7 million clients with more than $62 billion in assets under custody, collaborating with thousands of employers, plan sponsors, recordkeepers, and third-party administrators. Inspira Financial offers a range of services, including automatic rollover solutions, health savings accounts, emergency savings funds, and custody services, all designed to help clients effectively plan, save, and invest for a secure future. Through its innovative approach, Inspira Financial is dedicated to improving outcomes for clients and their beneficiaries.

Arctic Wolf

Series C in 2018
Arctic Wolf Networks, Inc., established in 2012 and headquartered in Eden Prairie, Minnesota, specializes in providing comprehensive cybersecurity solutions to businesses. The company offers a suite of services including Managed Detection and Response, Managed Risk, and Managed Cloud Monitoring, delivered through its unique concierge security team model. This approach extends the capabilities of clients' internal teams, offering tailored threat detection, response, and ongoing risk management. Arctic Wolf's platform employs continuous vulnerability assessment, real-time monitoring, and machine learning to provide actionable insights and alerts, enabling businesses to proactively combat cyber threats without needing to invest in their own security operations center. The company serves a diverse range of industries, with a particular focus on financial services, healthcare, legal enterprises, and other mid-to-large sized organizations.

Qpex Biopharma

Series A in 2018
Qpex Biopharma is a San Diego-based biopharmaceutical company founded in 2018, focused on developing innovative therapies to address the growing challenge of antimicrobial resistance. The company specializes in creating a pipeline of antibiotic drugs aimed at treating infectious diseases in both inpatient and outpatient settings. With a strong emphasis on the discovery, development, and regulatory approval of anti-infective medicines, Qpex Biopharma leverages its expertise and experience in collaboration with public and private partnerships to meet critical medical needs. The company's mission is to provide effective solutions for healthcare professionals facing the complexities of resistant infections, thereby enhancing treatment options for patients.

Cirius Therapeutics

Series A in 2018
Cirius Therapeutics, Inc. is a clinical-stage pharmaceutical company dedicated to developing and commercializing therapies for liver and metabolic diseases. Founded in 2015 and headquartered in San Diego, California, the company is focused on its lead product candidate, MSDC-0602K, an oral small molecule currently undergoing Phase 2b clinical trials for the treatment of nonalcoholic steatohepatitis (NASH) with fibrosis. MSDC-0602K operates as a next-generation insulin sensitizer, aiming to address the underlying pathophysiology of NASH, which is characterized by fat accumulation and inflammation in the liver and can progress to severe conditions such as cirrhosis or liver cancer. Cirius Therapeutics seeks to provide innovative solutions for healthcare providers managing liver and metabolic diseases.

Millendo Therapeutics

Venture Round in 2018
Millendo Therapeutics is a biopharmaceutical company dedicated to developing innovative treatments for endocrine diseases resulting from hormone dysregulation. The company focuses on creating distinct and transformative therapies that address significant unmet medical needs in this area. By leveraging scientific advancements, Millendo aims to develop novel compounds that can effectively treat complex conditions, ultimately enhancing clinical care and improving the quality of life for patients, families, and caregivers.

TurnKey Vacation Rentals

Series D in 2018
TurnKey Vacation Rentals is a full-service property management company specializing in luxury and premium vacation rental homes in sought-after U.S. travel destinations. The company is recognized for delivering a consistent and high-quality guest experience akin to that of a fine hotel, while simultaneously enhancing the management and marketing efforts for vacation rental homeowners. TurnKey utilizes proprietary smart home technology, including digital smart locks and noise decibel monitors, to streamline operations and improve guest satisfaction. By integrating local teams with advanced technology, TurnKey aims to provide exceptional experiences for both guests and homeowners, ensuring every stay meets high standards of quality and service.

Cofense

Venture Round in 2018
Cofense specializes in anti-phishing threat management solutions, protecting businesses from phishing, malware, and drive-by attacks. Its key offerings include Cofense Triage for real-time attack insights, Cofense Reporter for employee reporting of suspicious emails, and Cofense Vision for comprehensive attack understanding. Additionally, Cofense provides intelligence services, a learning management system for cybersecurity awareness, and professional services such as consulting. Serving a wide range of industries, Cofense's platform leverages a global network of trained employees to report suspected threats, enhancing detection and response capabilities that complement existing email gateway technologies.

Dynamic Signal

Series E in 2018
Dynamic Signal, established in 2010 and headquartered in San Bruno, California, specializes in employee communication and engagement. Its platform connects companies with their employees, facilitating the dissemination of timely, relevant content across various channels and devices. This enhances productivity, fosters employee engagement, and amplifies corporate messaging. Dynamic Signal serves hundreds of global enterprises, including 85 Fortune 500 companies, such as IBM, Salesforce, and Edelman.

Partner Therapeutics

Series A in 2018
Partner Therapeutics, Inc. is an oncology company based in Lexington, Massachusetts, dedicated to the development and commercialization of approved and late-stage cancer therapies. The company focuses on improving treatment outcomes and reducing overall healthcare costs for cancer patients through a comprehensive range of therapies, from primary treatments to supportive care. One of its key products is Leukine, which promotes the growth of white blood cells to aid in cancer treatment. Founded in 2017, Partner Therapeutics aims to connect investigators and healthcare professionals in the field of oncology, ensuring effective treatments are accessible to patients at all stages of their cancer journey.

MATRIXX Software

Series C in 2018
MATRIXX Software, Inc. is a developer of cloud-native digital commerce solutions that revolutionize business operations for companies worldwide. Established in 2008 and headquartered in Saratoga, California, with additional offices in London, Dubai, Singapore, and Australia, the company offers a modern commerce platform capable of scaling to meet the demands of global marketplaces and consumption-based services. Their platform allows users to create digital propositions across various services, including voice and data, while facilitating on-demand purchasing and management through mobile and digital channels. MATRIXX Software's solutions enable flexible charging models, including prepaid, postpaid, and hybrid options, along with integrated billing and support for Pay Now card payments. The company primarily serves communications firms, Internet of Things (IoT) providers, and digital service organizations, equipping them with the tools needed for operational agility and efficient infrastructure management.

Therapy Brands

Venture Round in 2018
Therapy Brands is a provider of software solutions specifically designed for mental and behavioral health practitioners. Headquartered in Birmingham, Alabama, the company offers fully integrated practice management and electronic health record systems tailored for various segments, including psychiatric care, substance use recovery, rehabilitation, and applied behavior analysis. By delivering a comprehensive suite of tools, Therapy Brands enables healthcare providers to enhance patient care and achieve better health outcomes. Their solutions streamline essential functions such as practice management, telehealth, revenue cycle management, e-Prescribing, and payment processing. This focus on operational efficiency allows therapists, psychologists, social workers, and counselors to reduce administrative burdens, thereby dedicating more time to patient interactions and improving overall service delivery.

Atox Bio

Series F in 2017
Atox Bio Inc. is a biotechnology company based in Ness Ziona, Israel, with an additional office in North Carolina. Founded in 2003, the company specializes in developing immunomodulators aimed at treating critically ill patients facing severe acute inflammation due to infections. Atox Bio focuses on novel modulators of the immune response, targeting both adaptive and innate pathways that play crucial roles in managing infectious and inflammatory diseases, as well as ischemia/reperfusion injuries. The company's products are designed to improve outcomes for patients suffering from rare, life-threatening infections, demonstrating significant improvements in various clinical endpoints. By enhancing the host's ability to combat infections and minimizing tissue damage during acute inflammatory events, Atox Bio aims to address serious unmet medical needs in critical care settings.

Outpost Medicine

Series A in 2017
Outpost Medicine is a biotechnology company founded in 2016 and based in the United States, focusing on the development of novel therapeutics for urologic and gynecologic diseases and disorders. The company is dedicated to creating innovative treatments for conditions such as overactive bladder and irritable bowel syndrome. Its lead clinical-stage product candidate, OP-233, targets stress urinary incontinence, a condition characterized by involuntary urine loss during physical activities that exert pressure on weakened pelvic floor muscles or urethral sphincters. Through its research and development efforts, Outpost Medicine aims to address significant unmet medical needs in these areas.

ThreatQuotient

Series C in 2017
ThreatQuotient, Inc. is a company that specializes in developing a threat intelligence platform designed to help organizations manage and respond to cyber threats effectively. Founded in 2013 and headquartered in Reston, Virginia, with additional operations in Germany and Australia, ThreatQuotient offers a platform that integrates and correlates various external intelligence sources with internal security processes and analytics. This platform provides contextual and operationalized intelligence, enabling organizations to streamline their security operations by focusing on prioritized threats. Its features include Indicator Nurturing, which tailors indicators of compromise to specific infrastructures, and the automation of processes to enhance investigation efficiencies and collaboration among security teams. By integrating with existing technologies, ThreatQuotient’s solutions support multiple use cases such as incident response, threat hunting, and vulnerability management. The company has been recognized for its product excellence and leadership in the cybersecurity industry, receiving several awards for its contributions to enhancing security operations.

Fusion Pharmaceuticals

Series A in 2017
Fusion Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in Hamilton, Canada, specializing in the development of next-generation radiopharmaceuticals as precision medicines for challenging cancers. The company leverages its Targeted Alpha Therapies platform and proprietary Fast-Clear linker technology to connect alpha particle-emitting isotopes with antibodies and other targeting molecules, enabling selective delivery of cytotoxic payloads to tumors. Its lead product candidate, FPI-1434, is currently undergoing Phase 1 clinical trials as a monotherapy for solid tumors expressing insulin-like growth factor 1 receptor. Additionally, Fusion is conducting preclinical studies to explore the combination of FPI-1434 with approved checkpoint inhibitors and DNA damage response inhibitors to enhance anti-tumor activity. The company is also advancing FPI-1966, aimed at treating head and neck and bladder cancers that express fibroblast growth factor receptor. Founded in 2014, Fusion Pharmaceuticals aims to innovate within the field of radiopharmaceuticals, transforming internalizing antibodies into effective cytotoxic drugs for improved cancer treatment outcomes.

Lever

Series C in 2017
Lever, Inc. is a talent acquisition company based in San Francisco, California, that offers a comprehensive web application designed to streamline the hiring process. The platform integrates applicant tracking system (ATS) and customer relationship management (CRM) capabilities into a single product, known as LeverTRM. It provides a range of tools for talent teams, including job postings, referrals, interview scheduling, and decision-making workflows. Lever also features analytics for data visualization and customized reporting, which aid in making informed strategic hiring decisions. The platform emphasizes inclusivity in hiring, aiming to reduce bias and foster authentic relationships between companies and potential candidates. Lever serves over 3,800 organizations globally, including notable companies such as Netflix, Atlassian, KPMG, and McGraw-Hill Education.

Solera Health

Series B in 2017
Solera Health, Inc. is a preventive care benefits manager based in Phoenix, Arizona, that operates a technology platform designed to connect payers, doctors, patients, and non-clinical healthcare providers. Founded in 2015, Solera's platform serves as a single marketplace for health plans and medical providers, facilitating access to community organizations and digital therapeutics that address a variety of health concerns, including obesity, hypertension, diabetes prevention, mental health, and tobacco cessation. By matching members with tailored health programs, Solera emphasizes value-based health solutions that ensure timely access to appropriate health technologies and promote improved health outcomes.

MyHealthTeam

Series A in 2017
MyHealthTeams, Inc., established in 2011 and headquartered in San Francisco, develops and operates online social networking platforms for individuals living with or caring for those with chronic health conditions. The company's platforms, including MyAutismTeam, MyBCTeam, and others, connect users with similar conditions, enabling them to share experiences, seek advice, and access medically-approved content. MyHealthTeams also conducts research to inform clinical trial design and offers patient education programs.

Mintigo

Series E in 2017
Mintigo Inc. is a company that specializes in developing an artificial intelligence-based customer engagement and predictive analytics platform tailored for B2B marketing and lead generation. Founded in 2009 and headquartered in San Mateo, California, Mintigo's platform enables businesses to identify customer buying tendencies and optimize engagement strategies. The company offers a range of solutions, including predictive ideal customer profile (ICP) discovery, audience generation, account-based marketing, and customer marketing for upselling and cross-selling. By employing advanced data science techniques, Mintigo empowers marketing and sales teams to gain insights into ideal prospects, personalize their outreach, and ultimately shorten the sales cycle. Its clientele includes notable companies such as Getty Images, Oracle, and Red Hat. As of October 2019, Mintigo operates as a subsidiary of Anaplan, Inc.

Smule

Series H in 2017
Smule, Inc. is a San Francisco-based company that specializes in developing music applications aimed at connecting users through collaborative music creation. Founded in 2008, Smule's platform allows individuals to sing and produce music together, fostering a global community of music enthusiasts. Its popular products include AutoRap, Magic Piano, Guitar!, I Am T-Pain, and Ocarina, which enable users to create, discover, and enjoy music in innovative ways. By combining social interaction with music-making, Smule has established itself as a leader in the music app industry, facilitating connections between users and major artists worldwide.

Snow Software

Venture Round in 2017
Snow Software is a technology intelligence company that specializes in asset management software aimed at helping organizations effectively manage their technology consumption. Its platform offers comprehensive visibility and insight into software, SaaS, hardware, and cloud resources. By automating the reconciliation of license entitlements with actual software installations and monitoring both cloud and on-premise usage, Snow Software enables clients to optimize their software licenses and reduce costs. Additionally, the platform features mobile license management, user authentication, and advanced analytics, which equip IT leaders with the necessary tools to enhance performance and operational agility in a hybrid work environment.

Cirius Therapeutics

Series A in 2017
Cirius Therapeutics, Inc. is a clinical-stage pharmaceutical company dedicated to developing and commercializing therapies for liver and metabolic diseases. Founded in 2015 and headquartered in San Diego, California, the company is focused on its lead product candidate, MSDC-0602K, an oral small molecule currently undergoing Phase 2b clinical trials for the treatment of nonalcoholic steatohepatitis (NASH) with fibrosis. MSDC-0602K operates as a next-generation insulin sensitizer, aiming to address the underlying pathophysiology of NASH, which is characterized by fat accumulation and inflammation in the liver and can progress to severe conditions such as cirrhosis or liver cancer. Cirius Therapeutics seeks to provide innovative solutions for healthcare providers managing liver and metabolic diseases.

Visier

Series D in 2017
Visier, Inc. is a developer of a cloud-based workforce intelligence platform that provides organizations with comprehensive analytics and solutions for managing their workforce. Founded in 2010 and headquartered in Vancouver, Canada, with an additional office in San Jose, California, Visier's offerings enable human resources professionals to efficiently recruit, retain, and develop talent while providing insights into workforce dynamics. The platform, known as Visier People, includes pre-built analytics that address a wide range of HR and business questions, facilitating strategic decision-making. It caters to various industries, including healthcare, financial services, technology, energy, manufacturing, and retail. Visier's subscription model ensures ongoing support and continuous delivery of new business value, enhancing the overall effectiveness of workforce planning and people analytics for its clients.

TurnKey Vacation Rentals

Series C in 2017
TurnKey Vacation Rentals is a full-service property management company specializing in luxury and premium vacation rental homes in sought-after U.S. travel destinations. The company is recognized for delivering a consistent and high-quality guest experience akin to that of a fine hotel, while simultaneously enhancing the management and marketing efforts for vacation rental homeowners. TurnKey utilizes proprietary smart home technology, including digital smart locks and noise decibel monitors, to streamline operations and improve guest satisfaction. By integrating local teams with advanced technology, TurnKey aims to provide exceptional experiences for both guests and homeowners, ensuring every stay meets high standards of quality and service.

Scytl

Series D in 2017
Scytl is a leading provider of electronic voting and electoral modernization solutions, specializing in secure and auditable electoral processes. Established in 2001 as a spin-off from a university research group, the company has developed a robust patent portfolio, holding over 40 international patents focused on election security. Its technology employs advanced cryptographic protocols, ensuring maximum security, transparency, and auditability for electoral events. Scytl has successfully managed over 100,000 electoral events in more than 35 countries, demonstrating its commitment to innovation and reliability in election administration. The company's solutions have been rigorously audited by independent organizations and academic experts, affirming compliance with high security standards. Headquartered in Barcelona, Spain, Scytl also operates strategic offices in Canada, the United States, Peru, and Greece, along with field offices in various countries. The company has experienced substantial growth, establishing a strong financial reputation within the industry.

Included Health

Venture Round in 2017
Included Health is a healthcare company that provides a blend of virtual care, navigation, and community-based healthcare services to enhance the member experience. It combines advanced technology and a compassionate approach to deliver personalized care guidance and advocacy, ensuring that individuals receive the right care at the right time. The company's offerings include access to both virtual and in-person services for a range of healthcare needs, including urgent and primary care, behavioral health, and specialty care. By focusing on a member-centric model, Included Health aims to raise the standard of healthcare for everyone, making it simpler and more effective for individuals to navigate their health journey.

Tripping.com

Series C in 2016
Tripping International, Inc. operates Tripping.com, a leading metasearch platform for vacation homes and short-term rentals globally. Launched in 2010 and based in San Francisco, the platform allows users to search, compare, and book accommodations from various partner rental sites, catering to families, large groups, and travelers seeking unique stays. With access to over 10 million properties in more than 150,000 destinations, Tripping.com offers a diverse range of options, including beach houses, condos, cabins, and apartments. The company emerged from TechCrunch Disrupt and has successfully secured multiple funding rounds, attracting investment from sources in Silicon Valley, New York, Europe, and Asia. As of December 2018, Tripping International operates as a subsidiary of HomeToGo GmbH.

Sauce Labs

Venture Round in 2016
Sauce Labs Inc. is a leading provider of cloud-based testing solutions for mobile and web applications, headquartered in San Francisco, California, with a data center in Frankfurt, Germany. Founded in 2008, the company offers a comprehensive testing platform that includes automated browser testing, mobile testing, and various testing services for different programming environments. Its flagship product, the Sauce Continuous Testing Cloud, has facilitated over 3 billion tests, enabling businesses to ensure their applications perform optimally across various browsers, operating systems, and devices. By delivering insights into the user experience, Sauce Labs helps organizations enhance software quality, protect their brand reputation, and speed up product delivery. Co-founded by the original creator of Selenium, Sauce Labs maintains strong ties to the open-source community, providing a unique blend of expertise and customer support in the automated testing space.

CareCloud

Series C in 2016
CareCloud Corporation is a healthcare information technology company based in Miami, Florida, founded in 2009. It specializes in cloud-based solutions, offering a comprehensive suite of services that includes practice management, electronic health records, revenue cycle management, and patient engagement tools. CareCloud caters to various medical specialties such as dermatology, family practice, ophthalmology, podiatry, rheumatology, and urology. By leveraging its innovative software-as-a-service platforms, the company aims to enhance profitability, streamline workflows, and improve patient care for medical groups across the United States. CareCloud's data-driven tools provide actionable insights, facilitating effective management of the financial and administrative aspects of healthcare delivery. The company currently manages over $4 billion in annualized accounts receivable on its integrated clinical and financial platform. As of early 2020, CareCloud operates as a subsidiary of MTBC, Inc.

TrendKite

Series D in 2016
TrendKite is an Austin, Texas-based company founded in 2012, specializing in public relations (PR) analytics software. The company's mission is to assist organizations in understanding public perception and responding effectively. TrendKite's platform provides comprehensive tools for measuring the impact of PR efforts on brand awareness, website traffic, and overall business objectives. It enables users to create automated or customizable dashboards that can swiftly analyze vast amounts of data, streamlining workflow and improving efficiency. The software is designed to help brands and agencies evaluate trends across various media types, generate insightful reports, and focus on the quality of media coverage rather than merely the quantity.

Exabeam

Venture Round in 2016
Exabeam, Inc. is a cybersecurity company that specializes in developing a security management platform designed to enhance threat detection, investigation, and response. Its technology leverages user and entity behavior analytics to identify risky activities and improve incident response through automation. The platform integrates log data to create coherent timelines of user activities across multiple accounts and devices, allowing analysts to swiftly assess and address potential threats. Exabeam's offerings include advanced tools such as Threat Hunter for security intelligence, a cloud-based Threat Intelligence Service that aggregates threat indicators, and Exabeam Data Lake for storing critical log data. The company provides solutions applicable to various security challenges, including insider threats and data loss prevention. Established in 2013 and headquartered in San Mateo, California, Exabeam has formed strategic partnerships with other cybersecurity firms to enhance its service offerings.

Smule

Series G in 2016
Smule, Inc. is a San Francisco-based company that specializes in developing music applications aimed at connecting users through collaborative music creation. Founded in 2008, Smule's platform allows individuals to sing and produce music together, fostering a global community of music enthusiasts. Its popular products include AutoRap, Magic Piano, Guitar!, I Am T-Pain, and Ocarina, which enable users to create, discover, and enjoy music in innovative ways. By combining social interaction with music-making, Smule has established itself as a leader in the music app industry, facilitating connections between users and major artists worldwide.

Aptinyx

Series A in 2016
Aptinyx Inc. is a clinical-stage biopharmaceutical company based in Evanston, Illinois, that specializes in discovering and developing innovative therapies for disorders of the brain and nervous system. Founded in 2015, the company focuses on proprietary synthetic small molecules that modulate the NMDA receptor, enhancing nerve cell communication. Aptinyx's pipeline includes NYX-2925, which is in Phase II clinical development for painful diabetic peripheral neuropathy and fibromyalgia, and NYX-783, currently in Phase I trials for post-traumatic stress disorder. Additionally, NYX-458, another NMDA receptor modulator, is undergoing Phase I studies aimed at treating cognitive impairment associated with Parkinson's disease. The company also collaborates with Allergan plc to develop a compound for major depressive disorder, highlighting its commitment to addressing significant unmet medical needs in the central nervous system arena.

Couchbase

Series F in 2016
Couchbase, Inc. is a provider of NoSQL database solutions designed for enterprise web and mobile applications. The company's flagship product, Couchbase Server, is an open-source, document-oriented database optimized for high-performance, interactive applications. Couchbase also offers a comprehensive platform that includes Couchbase Lite, a lightweight embedded database for mobile devices, and Couchbase Sync Gateway, which facilitates data synchronization between devices and the cloud. Additionally, Couchbase provides a fully-managed Database-as-a-Service (DBaaS) known as Couchbase Cloud, tailored for multi-cloud environments, as well as a Kubernetes Operator for cloud-native database management. The company's solutions are utilized across various industries, including social networking, e-commerce, gaming, and media. Headquartered in Santa Clara, California, Couchbase also has a presence in Manchester, United Kingdom. The company, originally founded as Membase, Inc. in 2008, rebranded as Couchbase, Inc. in 2011.

Outpost Medicine

Series A in 2016
Outpost Medicine is a biotechnology company founded in 2016 and based in the United States, focusing on the development of novel therapeutics for urologic and gynecologic diseases and disorders. The company is dedicated to creating innovative treatments for conditions such as overactive bladder and irritable bowel syndrome. Its lead clinical-stage product candidate, OP-233, targets stress urinary incontinence, a condition characterized by involuntary urine loss during physical activities that exert pressure on weakened pelvic floor muscles or urethral sphincters. Through its research and development efforts, Outpost Medicine aims to address significant unmet medical needs in these areas.

Millendo Therapeutics

Series B in 2016
Millendo Therapeutics is a biopharmaceutical company dedicated to developing innovative treatments for endocrine diseases resulting from hormone dysregulation. The company focuses on creating distinct and transformative therapies that address significant unmet medical needs in this area. By leveraging scientific advancements, Millendo aims to develop novel compounds that can effectively treat complex conditions, ultimately enhancing clinical care and improving the quality of life for patients, families, and caregivers.

HealthFinch

Series A in 2016
Healthfinch, Inc. is a healthcare IT company based in Madison, Wisconsin, founded in 2011. It specializes in developing technology aimed at streamlining prescription renewal requests and other routine clinical tasks for health systems. The company's flagship offering, the Charlie Practice Automation Platform, utilizes electronic medical record (EMR) data to automate and simplify workflows related to prescription refills, visit planning, and management of diagnostic results. By integrating seamlessly with major EMR systems such as Allscripts, Epic, and athena, Healthfinch's solutions enhance the efficiency of clinics and healthcare providers by reducing the burden of repetitive tasks, thereby allowing healthcare professionals to focus more on patient care. As of July 31, 2020, Healthfinch operates as a subsidiary of Health Catalyst, Inc.

Skybox Security

Venture Round in 2016
Skybox Security, Inc. specializes in cybersecurity management solutions tailored for enterprises. The company offers a comprehensive Security Posture Management Platform that enhances visibility, analytics, and automation across corporate networks and cloud environments. Its key products include Skybox Horizon, which provides insight into the attack surface; Skybox Vulnerability Control, which focuses on context-aware vulnerability management; and Skybox Threat Manager, which offers threat intelligence analysis and response services. Additionally, Skybox Firewall Assurance ensures firewall security and compliance, while Skybox Change Manager streamlines the firewall change management process. The company serves a diverse range of industries, including financial services, government, energy, technology, telecommunications, and healthcare. Founded in 2002 and headquartered in San Jose, California, Skybox Security also maintains offices in various regions, including Europe, Asia-Pacific, and South Africa.

CBANC

Series B in 2015
CBANC is an online professional network designed specifically for bank and credit union professionals. Established in 2009 and headquartered in Austin, Texas, the company provides a suite of tools that facilitate collaboration and information sharing among community financial institutions. Its offerings include resources for document management, discussions, vendor management, peer group analysis, and risk assessment. By leveraging the collective knowledge of its members, CBANC aims to empower employees within financial institutions to navigate compliance challenges, make informed vendor decisions, and enhance their professional development. Ultimately, the company is committed to supporting the independence and growth of community banking, fostering a healthier financial future for its members.

Earnest

Series B in 2015
Earnest Operations LLC is a financial services company based in San Francisco, California, that specializes in student loan refinancing, private student loans, and personal loans. Founded in 2013, the company aims to simplify the loan process for responsible borrowers by utilizing advanced technology that evaluates more than just credit scores, incorporating factors such as education, savings habits, and career paths. Earnest offers a range of private student loans, including options for undergraduate, graduate, medical, and law school, as well as personal loans for purposes like credit card consolidation, home improvement, and weddings. Since its inception, Earnest has expanded significantly, distributing nearly $2 billion in student loans by 2017. In that year, it was acquired by Navient Corporation, which maintains Earnest as a distinct brand while providing operational support. The company serves clients in 45 states and the District of Columbia, providing an online platform for loan management and customer service.

MyHealthTeam

Series A in 2015
MyHealthTeams, Inc., established in 2011 and headquartered in San Francisco, develops and operates online social networking platforms for individuals living with or caring for those with chronic health conditions. The company's platforms, including MyAutismTeam, MyBCTeam, and others, connect users with similar conditions, enabling them to share experiences, seek advice, and access medically-approved content. MyHealthTeams also conducts research to inform clinical trial design and offers patient education programs.

Corvus Pharmaceuticals

Series B in 2015
Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Burlingame, California, specializing in the development of immuno-oncology therapies. The company focuses on creating first-in-class agents that modulate the immune system to treat cancer and other diseases. Its lead product candidate, Ciforadenant (CPI-444), is an oral small molecule antagonist of the A2A receptor currently undergoing Phase Ib/2 clinical trials. Additionally, Corvus is developing CPI-006, an anti-CD73 monoclonal antibody in Phase I/Ib trials aimed at inhibiting adenosine production and stimulating immune cells, as well as a Phase I trial for COVID-19. Another candidate, CPI-818, is a small molecule inhibitor targeting interleukin-2-inducible T-cell kinase, also in Phase I/Ib trials. The company has established a strategic collaboration with Angel Pharmaceuticals to further advance its pipeline of investigational medicines. Founded in 2014, Corvus Pharmaceuticals aims to contribute significantly to the field of immunotherapy and improve patient outcomes in various diseases.

Cybera

Private Equity Round in 2015
Cybera, Inc. is a provider of Security-as-a-Service virtual application networks, specializing in networking and security solutions for distributed enterprises both in the United States and internationally. Founded in 2000 and based in Franklin, Tennessee, the company offers a software-defined networking and network function virtualization platform designed to optimize security and connectivity for multi-location businesses. Cybera's services address regulatory compliance needs, such as PCI and HIPAA, while safeguarding sensitive corporate data and protecting consumers from identity theft. The company's offerings include a network security platform, endpoint protection, and fully managed security services, all tailored for various sectors including healthcare, retail, hospitality, and financial services. Cybera's solutions streamline operations through a consolidated network overlay, reducing complexity and costs while providing a straightforward billing process and cost-effective equipment options. As of December 2020, Cybera operates as a subsidiary of Professional Datasolutions, Inc.

Orbus Therapeutics

Series A in 2015
Orbus Therapeutics, Inc., established in 2012 and based in Palo Alto, California, is a biopharmaceutical company dedicated to developing and commercializing therapies for rare diseases, with a focus on brain cancers. Its lead product, Eflornithine, is an orally bioavailable small molecule that acts as a cytostatic agent, inhibiting tumor growth by targeting ornithine decarboxylase (ODC). Currently, Orbus Therapeutics is working to bring Eflornithine to patients in North America affected by recurrent anaplastic astrocytoma, a rare and life-threatening form of central nervous system cancer. The company's mission is to improve the health and quality of life for these underserved patients by delivering innovative products that offer more positive outcomes.

Apto

Series B in 2015
Apto, Inc., headquartered in Denver, Colorado, develops cloud-based software specifically for commercial real estate brokers. Founded in 2011, Apto provides a web-based platform that facilitates the management of contacts, properties, listings, and deals, streamlining the entire deal lifecycle from prospecting to closing. The software enhances operational efficiency by consolidating, organizing, and securely storing critical data, enabling brokers to execute transactions more effectively. By utilizing Apto's tools, clients can ensure that essential details are managed systematically, allowing them to focus on finding and winning deals.

RadiumOne

Series C in 2015
RadiumOne is a software company that specializes in programmatic marketing automation, enabling digital marketers to effectively utilize big data. Founded in 2009 and headquartered in San Francisco, California, the company offers a platform that automates media buying, connecting brands with potential customers by leveraging proprietary data on consumer behaviors, actions, and interests across various web and mobile touchpoints. This capability allows businesses to enhance customer engagement through relevant and personalized offers, messages, content, and advertisements, facilitating targeted marketing across multiple devices and locations.

Chrome River Technologies

Series D in 2015
Chrome River Technologies, Inc. specializes in automated expense and invoice management solutions designed for a variety of industries, including legal, healthcare, and technology. Founded in 2007 and headquartered in Los Angeles, with additional offices in Canada, the United Kingdom, Germany, France, India, and Australia, the company offers a suite of cloud-based products. These include Chrome River EXPENSE, which ensures real-time compliance with spending policies, and Chrome River INVOICE, which streamlines the invoice management process. The company also provides tools for fraud management, corporate card reconciliation, and expense reporting, complemented by robust analytics capabilities. With a focus on delivering an intuitive user experience across devices, Chrome River Technologies aims to enhance operational efficiency and support organizations in managing their financial workflows effectively. As of 2019, it operates as a subsidiary of Certify Inc.

Smule

Series F in 2015
Smule, Inc. is a San Francisco-based company that specializes in developing music applications aimed at connecting users through collaborative music creation. Founded in 2008, Smule's platform allows individuals to sing and produce music together, fostering a global community of music enthusiasts. Its popular products include AutoRap, Magic Piano, Guitar!, I Am T-Pain, and Ocarina, which enable users to create, discover, and enjoy music in innovative ways. By combining social interaction with music-making, Smule has established itself as a leader in the music app industry, facilitating connections between users and major artists worldwide.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.